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ABSTRACT
Themicrotubule depolymerising kinesin-13,MCAK, is phosphorylated at residue T537
by Cdk1. This is the only known phosphorylation site within MCAK’s motor domain.
To understand the impact of phosphorylation by Cdk1 on microtubule depolymerisa-
tion activity, we have investigated the molecular mechanism of the phosphomimic mu-
tant T537E. This mutant significantly impairs microtubule depolymerisation activity
and when transfected into cells causes metaphase arrest and misaligned chromosomes.
We show that the molecular mechanism underlying the reduced depolymerisation
activity of this phosphomimic mutant is an inability to recognise the microtubule end.
The microtubule-end residence time is reduced relative to wild-type MCAK, whereas
the lattice residence time is unchanged by the phosphomimic mutation. Further, the
microtubule-end specific stimulation of ADP dissociation, characteristic of MCAK, is
abolished by this mutation. Our data shows that T537E is unable to distinguish between
the microtubule end and the microtubule lattice.
Subjects Biochemistry, Biophysics, Molecular Biology
Keywords MCAK, Kinesin-13, Microtubule end recognition, Depolymerisation, Microtubule,
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INTRODUCTION
Mitotic Centromere Associated Kinesin (MCAK) is a member of the kinesin-13 family
of microtubule depolymerising kinesins. MCAK plays crucial roles in the cell cycle both
in building the mitotic spindle and in correcting erroneous microtubule-kinetochore
attachments. Therefore, both the localisation and depolymerisation activity of MCAK
must be tightly regulated throughout the cell cycle. This regulation is primarily achieved
through phosphorylation.
MCAK is regulated through the action of various mitotic kinases, including the aurora
kinases, polo like kinase 1 and p21 activated kinase 1 (Andrews et al., 2004; Lan et al.,
2004; Pakala et al., 2012; Zhang et al., 2011; Zhang, Ems-McClung & Walczak, 2008). These
kinases phosphorylate MCAK at various sites within the N and C-terminal domains
and in the neck region. Only one phosphorylation site within MCAK’s motor domain
has been identified to date. Threonine 537, which is located adjacent to the α4 helix
on the tubulin-binding face of the motor domain (Fig. 1A), is phosphorylated by the
cyclin-dependant kinase Cdk1 (Sanhaji et al., 2010). A phosphomimic mutant at this
position, T537E, has reduced depolymerisation activity and overexpression of this mutant
in cells leads to misaligned chromosomes, metaphase arrest and reduced intercentromeric
distances (Sanhaji et al., 2010).
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Figure 1 The phosphomimic mutant T537E has reduced depolymerisation activity and reduced
microtubule-stimulated ATPase activity. (A) Location of T537 in the crystal structure of the MCAK
motor domain (PDB ID: 2HEH). T537 (red) is located adjacent to the α4 helix. The α4 helix, loop 2
and loop 8 are at the microtubule binding interface of MCAK. The nucleotide is shown in dark blue. (B)
Depolymerisation rate of WT MCAK and T537E mutant. Distribution of depolymerisation rates of single
microtubules after the addition of 40 nMMCAK. The box represents the central 50% of the distribution,
the central line the median and the whiskers the 10th–90th percentile. (C) ATPase rate of WT MCAK and
T537E mutant in solution, in the presence of 10 µM unpolymerised tubulin and in the presence of 10 µM
microtubules. Error bars are±standard deviation.
Full-size DOI: 10.7717/peerj.4034/fig-1
MCAK is a specialist microtubule depolymerising kinesin and its ATP turnover cycle is
tailored to this function. While many kinesins have a translocating, ‘‘walking’’ action along
the microtubule, MCAK diffuses on the microtubule lattice in the ADP-bound state. The
microtubule end specifically accelerates ADP dissociation, stimulating exchange of ADP
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for ATP, which allows MCAK to bind tightly at the end of the microtubule. The binding of
ATP.MCAK at the microtubule end promotes dissociation of tubulin dimers and thereby
microtubule depolymerisation (Friel & Howard, 2011).
To understand how phosphorylation by Cdk1 impairs MCAK’s depolymerisation
activity we studied the effect of the phosphomimic substitution T537E on the molecular
mechanism of microtubule depolymerisation. Here we show that the phosphomimic
mutant, T537E, cannot distinguish between the microtubule end and the microtubule
lattice, an ability characteristic of wild-type MCAK and other kinesins which regulate
microtubule dynamics.
METHODS
Proteins
Full length humanMCAK-his6 andMCAK-his6-EGFP inwild type andmutated formswere
expressed in Sf9 cells (Invitrogen, Carlsbad, CA, USA) and purified using nickel affinity
chromatography as described previously (Helenius et al., 2006). MCAK concentrations
are given as monomer concentrations. Porcine brain tubulin was purified as described
previously (Castoldi & Popov, 2003). Single cycled, fluorescently labelled microtubules and
double cycled microtubules were prepared as described previously (Patel et al., 2016). The
concentration of microtubules is given as the concentration of polymerised tubulin.
Microtubule depolymerisation
Microtubule depolymerisation rates were determined by measuring the length of
immobilised, GMPCPP-stabilised, rhodamine labelled, single cycled microtubules over
time after the addition of 40 nM MCAK as described previously (Patel et al., 2016).
ATPase assays
ATPase rates in solution weremeasured using 3µMMCAK andmonitoring the production
of ADP by HPLC as described previously (Friel, Bagshaw & Howard, 2011; Friel & Howard,
2011; Patel et al., 2016). For assays with tubulin or double-cycled microtubules 0.1 µM
MCAK was used and the production of ADP was monitored by linking it to the oxidation
of NADH (De La Cruz & Ostap, 2009). For both assays the change in concentration of
ADP per second was divided by the concentration of MCAK to give the ATPase activity
per second per motor domain.
Single molecule TIRF assays
Single molecules of MCAK-GFP were observed on immobilised, GMPCPP-stabilised,
rhodamine labelled, single cycled, microtubules using TIRF microscopy as described
previously (Patel et al., 2016). Kymographs for individual microtubules were used to
measure the time individual MCAK-GFP molecules spent at the microtubule end and on
the lattice.
ADP dissociation assays
The dissociation of mantADP from MCAK was measured as described previously (Patel
et al., 2014), in solution or with the addition of 10 µM tubulin or 5.7 µM double cycled
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microtubules (chosen to have a comparable number of microtubule ends as the ATPase
assay with microtubules). The fluorescence traces were fitted to a single exponential,
or double exponential if required, with an additional linear function to account for the
photobleaching of mant.
RESULTS
The phosphomimic mutant T537E reduces depolymerisation activity
and microtubule-stimulated ATPase activity
Firstly, we confirmed the effect of the substitution T537E on MCAK’s depolymerisation
activity in vitro. It has been shown previously at high concentration (500 nM) that the
mutation T537E decreases depolymerisation activity 4-fold relative to wild-type MCAK
(Sanhaji et al., 2010).Wemeasured depolymerisation activity at 40 nM, the concentration at
which the fastest microtubule depolymerisation for wild-type MCAK is observed (Helenius
et al., 2006). Under these conditions the phosphomimicmutant had a depolymerisation rate
50-fold slower than the wild-type (0.06±0.06 µmmin−1 and 3.04±0.53 µmmin−1 (mean
± standard deviation), respectively) (Fig. 1B). Thus, confirming that the phosphomimic
substitution dramatically decreases MCAK’s depolymerisation activity.
We nextmeasured the ATPase activity of T537E in the absence of tubulin, in the presence
of unpolymerized tubulin and in the presence of microtubules. The ATPase rate of the
T537Emutant in solution was not significantly different to wild type (5.33±0.33×10−3s−1
comparedwith 4.47×10−3±2.60×10−3s−1, p= 0.6002) (Fig. 1C). Similarly, the ATPase in
the presence of unpolymerized tubulin was not significantly affected by the phosphomimic
mutation: 0.194 ± 0.055 s−1 compared with 0.299 ± 0.047 s−1 for wild-type MCAK,
p= 0.0658 (Fig. 1C). These data indicate that the phosphomimic mutant folds correctly
as it turns over ATP at a similar rate to wild-type both in solution and in the presence
of unpolymerized tubulin. These data also suggest that T537E can still interact with
unpolymerized tubulin, as its ATPase rate is accelerated by unpolymerized tubulin to the
same degree as wild type. By contrast, there is a dramatic difference in the microtubule-
stimulated ATPase activity of T537E relative to wild-type MCAK. The microtubule-
stimulated ATPase rate of T537E is 14-fold slower than wild type MCAK: 0.335 ± 0.081
s−1 and 4.75 ± 0.055 s−1, respectively (Fig. 1C). The ATPase rate for T537E was in fact
similar to the ATPase for both wild-type and T537E in the presence of unpolymerized
tubulin. The difference between the ATPase rates in the presence of unpolymerized tubulin
compared to the presence of microtubules for wild-type MCAK has previously been shown
to be due to the acceleration of ADP dissociation caused specifically by microtubule ends
(Friel & Howard, 2011). Therefore, the reduction in the ATPase of T537E to a similar
level to that in the presence of unpolymerized tubulin suggests this mutation may have
specifically impaired MCAK’s ability to recognise the microtubule end.
The mutation T537E abolishes long microtubule end residence
events
The ATPase activity of wild-type MCAK is maximally accelerated by microtubule ends
(Friel & Howard, 2011; Hunter et al., 2003). The residue T537 is near the α4 helix of
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Figure 2 T537E has few long microtubule-end binding events and the microtubule-end cannot accel-
erate mantADP dissociation. (A) (B) Kymographs showing the interaction of WT MCAK and the T537E
mutant (both green) with the microtubule (magenta). (C) (D) Histograms showing the end residence
time of single molecules of WT MCAK and T537E. (E) Average fluorescence traces for the dissociation of
mantADP fromWTMCAK (k = 0.102±0.013 s−1) and T537E (k = 0.114±0.013 s−1) in solution and for
T537E in the presence of 10 µM unpolymerised tubulin (k = 0.120±0.019 s−1). (F) Average fluorescence
traces for the dissociation of mantADP fromWTMCAK (k1= 4.11±0.41 s−1, k2= 0.341±0.051 s−1) and
T537E (k= 0.369±0.089 s−1) in the presence of 5.7 µMmicrotubules.
Full-size DOI: 10.7717/peerj.4034/fig-2
the MCAK motor domain (Fig. 1A). Residues in the α4 helix are critical to MCAK’s
ability to recognise the microtubule end (Patel et al., 2016). This proximity to the α4
helix together with the observation that the mutation T537E specifically impairs the
microtubule stimulated ATPase of MCAK suggests that this phosphomimic mutation may
also interfere with MCAK’s ability to distinguish the microtubule end from the lattice. We
used TIRF microscopy to observe the interaction of single molecules of MCAK-GFP and
T537E-GFP with microtubules. Wild type MCAK makes short diffusive interaction with
the microtubule lattice. However, when it reaches the microtubule end ADP dissociation
is accelerated, leading to nucleotide exchange and ATP. MCAK binds tightly and displays
longer microtubule end residence events (Fig. 2A). The MCAK mutant T537E displays
similar short diffusive interactions with the microtubule lattice but, by contrast with the
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Table 1 Compiled results of depolymerisation rate, ATPase activity, microtubule-end residence time
andmantADP dissociation rates for wild typeMCAK and T537E.
MCAK variant WT T537E
(µm/min) (mean± SD)
Depolymerisation rate 3.04± 0.53
(n= 20)
0.06± 0.06
(n= 20)
ATPase activity (s−1) (mean± SD)
Solution (basal) 0.0045± 0.0026
(n= 3)
0.0053± 0.0033
(n= 3)
Tubulin-stimulated 0.299± 0.047
(n= 3)
0.194± 0.055
(n= 3)
fMicrotubule-stimulated 4.75± 0.057
(n= 3)
0.335± 0.081
(n= 3)
(s) (mean± SEM)
Microtubule-end residence time 2.03± 0.13
(n= 289)
0.64± 0.02
(n= 242)
(nM−1 s−1) (mean± SD)
Microtubule-end interaction events 0.71± 0.29
(n= 15)
0.97± 0.27
(n= 17)
mantADP dissociationa (s−1) (mean± SD)
Solution 0.102± 0.013
(n= 3)
0.114± 0.013
(n= 3)
Tubulin-stimulated 0.114± 0.023
(n= 3)
0.120± 0.019
(n= 3)
Microtubule-stimulated First phase 4.11± 0.41
(n= 3)
0.369± 0.089
(n= 3)
Second phase 0.341± 0.051
(n= 3)
n/a
Notes.
aThe data and fits to the data from which these rate constants were obtained are shown in Fig. S2.
wild-type, does not show long end binding events (Fig. 2B). Quantification of microtubule
end residence times for wild-type MCAK and T537E shows that 32% of molecules for the
wild type but only 0.4% of molecules for T537E stayed at the microtubule end for longer
than 2 s (Figs. 2C and 2D). The lattice residence time for T537E is unchanged relative to
wild type (0.42 ± 0.01 s and 0.48 ± 0.02 s, respectively) and neither the association or
dissociation rates are significantly different (Fig. S1 and Table S1). These data indicate
that the affinity for the microtubule lattice is not significantly changed for this mutant. By
contrast, the end residence time for T537E was decreased to 0.64 ± 0.02 s compared to
2.03 ± 0.13 s for the wild type. In agreement with this, the rate of dissociation from the
microtubule end is increased relative to wild-type (Table S1). To investigate the possibility
that themutation had impairedMCAK’s ability to reach themicrotubule end, we calculated
the number of end interaction events per unit time for individual microtubules. This gave
values of 0.71 ± 0.29 nM−1 s−1 and 0.97 ± 0.27 nM−1 s−1 for wild-type and T537E,
respectively (Table 1). These data indicate that a similar number of MCAK molecules
reach the microtubule end for both wild-type and mutant and that the phosphomimic
mutation does not impair MCAK’s ability to reach the microtubule end. Rather, in the
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case of T537E, the average time a molecule remains at the microtubule end is significantly
reduced. Taken together, these data imply that the molecular mechanism underlying the
attenuation of depolymerisation activity due to this phosphomimic mutation is loss of
ability to distinguish between the microtubule end and the microtubule lattice.
The microtubule end does not accelerate ADP dissociation from
T537E
ATP turnover by MCAK is maximally accelerated by the microtubule end due to
microtubule end specific acceleration of ADP dissociation. To test whether the difference in
T537E interaction with the microtubule end had affected the ability of the microtubule end
to accelerate ADP dissociation, we measured the rate of dissociation of ADP tagged with
the small fluorophore mant (mantADP). In solution and in the presence of unpolymerised
tubulin, the rate constant for ADP dissociation was not significantly affected by this
mutation (WT 0.102 ± 0.013 s−1, T537E 0.114 ± 0.013 s−1, WT + Tb 0.114 ± 0.024 s−1,
T537E+ Tb 0.120± 0.019 s−1) (Table 1 and Fig. 2E). This is in agreement with the ATPase
activities under these conditions which are not significantly changed.
In the presence of microtubules, the change in fluorescence associated with mantADP
dissociation from wild type MCAK is best described by a double exponential function. The
two phases can be explained as a microtubule-end stimulated fast phase and a slower phase
corresponding to molecules which do not encounter the microtubule end (i.e. remain in
solution, in contact with unpolymerised tubulin or in contact with the microtubule lattice
over the course of the experiment). The fast phase of mantADP dissociation from wild type
MCAK measured here has a rate constant of 4.11 ± 0.41 s−1 and the slower phase a rate
constant of 0.341 ± 0.051 s−1. The rate constant for the slower phase is in close agreement
with the rate constant for mantADP dissociation fromMCAK in solution or in the presence
of unpolymerized tubulin. This is in agreement with this phase representing mantADP
dissociation from molecules which do not contact the microtubule end. By contrast with
WT-MCAK, the change in fluorescence associated with mantADP dissociation from T537E
was well described by a single exponential function with a rate constant of 0.369 ± 0.090
s−1. The faster phase was lost for the phosphomimicmutant indicating that themicrotubule
end cannot accelerate mantADP dissociation from T537E. In fact, the rate constant for the
single phase observed for mantADP dissociation from T537E was not significantly different
from the slower phase of mantADP dissociation from wild type MCAK (p= 0.6679, Fig. 2F
and Table 1). Further, the microtubule-stimulated mADP dissociation rate constant is also
similar to the rate constant in solution and in the presence of unpolymerized tubulin for
both wild-type MCAK and T537E. Therefore, despite single molecule TIRF data showing
that MCAK T537E can reach the microtubule end (Fig. 2B and Table 1), the kinetics of
ADP dissociation for this mutant are consistent with the kinetics of ADP dissociation for
wild-type MCAK when in solution, in the presence of unpolymerized tubulin or on the
microtubule lattice. These data suggest that the phosphomimic mutant T537E has lost the
ability to distinguish between the microtubule lattice and the microtubule end.
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DISCUSSION
To understand the molecular mechanism by which phosphorylation by Cdk1 impairs
MCAK’s depolymerisation activity, we studied the phosphomimic mutant T537E. This
mutation causes a 50-fold decrease in the rate of microtubule depolymerisation by
MCAK. Overexpression of this phosphomimic mutant in cells shows that it can localise
to centromeres but that chromosome alignment is disrupted and cells arrest in metaphase
(Sanhaji et al., 2010). The intra-centromere distance is decreased suggesting that cells
expressing this mutant form of MCAK cannot generate tension across centromeres or
correct erroneous chromosome attachments.
We have shown that, whilst the in solution and unpolymerized tubulin-stimulated
ATPase activity of the phosphomimic mutant are unchanged, the microtubule stimulated
ATPase is reduced 14-fold relative to wild-type MCAK. Single molecule TIRF analysis of
this mutant showed that this impact on the microtubule-stimulated ATPase was due to loss
of the ability of T537E to recognise the microtubule end. We saw that long end residence
times, characteristic of wild-type MCAK’s interaction with the microtubule, are abolished
by the T537E mutation. Further, T537E cannot undergo microtubule-end stimulated
acceleration of ADP dissociation, a crucial requirement for the depolymerisation activity of
MCAK. Together our data show that T537E, unlike wild-type MCAK, cannot distinguish
between the microtubule lattice and the microtubule end.
The localisation, abundance and activity of MCAK have all been shown to be regulated
by phosphorylation at positions outside the motor domain by the kinases Aurora A and
B, PLK1 and PAK1 (Andrews et al., 2004; Ohi et al., 2004; Pakala et al., 2012; Sanhaji et
al., 2014; Zhang, Ems-McClung & Walczak, 2008). The MCAK neck, which is required for
maximal microtubule depolymerisation activity (Cooper et al., 2010; Ems-McClung et al.,
2007; Ovechkina, Wagenbach & Wordeman, 2002), is phosphorylated by both PAK1 and
Aurora B kinase. Phosphorylation at this site inhibits depolymerisation activity (Lan et al.,
2004; Pakala et al., 2012). This down regulation is likely due to disruption of an interaction
between the neck-motor domain and C-terminal region required to allow MCAK to
enter a high-affinity, depolymerisation competent conformation at the microtubule end
(Ems-McClung et al., 2013). Phosphorylation of MCAK at its C-terminus by Aurora A has
similarly been suggested to disrupt interactions between the neck-motor and C-terminal
regions (Talapatra, Harker & Welburn, 2015).
The residue T537, the target of phosphorylation by Cdk1, is the only currently identified
phosphorylation site within the MCAK motor domain. This residue is located adjacent
to the C-terminal end of the α4 helix. The α4 helix has been suggested, on the basis of
currently available structures of Kinesin-13 motor domains (Asenjo et al., 2013; Ogawa et
al., 2004; Shipley et al., 2004;Wang et al., 2017), to play a role in deforming tubulin dimers
thereby destabilising the microtubule and promoting depolymerisation. The ATP turnover
cycle of MCAK differs from translocating kinesins and is adapted to promote tight binding
of MCAK at the microtubule end where it can have maximal depolymerising impact (Friel
& Howard, 2011). Previous work from our lab has shown that mutations in the α4 helix
impact the molecular mechanism of MCAK in the same way as the phosphomimic mutant
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described here (Patel et al., 2016). The proximity of T537 to the α4 helix may also provide
the key to why the T537E mutant is unable to distinguish between the microtubule lattice
and the microtubule end. The α4 helix is proposed to have a larger interface with tubulin
at the intradimer groove in a curved conformation of tubulin, as may be found at the
microtubule end, compared with a more constrained straight conformation within the
microtubule lattice (Asenjo et al., 2013; Ogawa et al., 2004; Wang et al., 2017). Disruption
of this crucial interface by mutation or by phosphorylation impairs MCAK’s ability to
distinguish different tubulin conformations and thereby recognise the microtubule end.
Our data shows that the T537E mutant, although significantly impaired in
depolymerisation activity, can interact with the microtubule lattice with an affinity similar
to wild-type MCAK. This mutant displays the characteristic diffusive interaction of MCAK
with the microtubule lattice and can still reach the microtubule end. Assuming that the
behaviour we have observed for this mutant is a good representation of the behaviour of
phosphorylated MCAK’s activity, MCAK phosphorylated at T537 is not prevented from
interacting withmicrotubules of themitotic spindle or being localised close to centromeres.
However, it is locked in an inactive state that is blocked from recognising the microtubule
end in the manner required to promote depolymerisation. Phosphorylation by Cdk1
holds MCAK in the set position; dephosphorylation is then the starter’s gun allowing
MCAK to instantly begin depolymerising kinetochore-attached microtubules at the correct
moment. Phosphorylation at the Cdk1 site, T537, rather than completely blockingMCAK’s
interaction with microtubules, holds MCAK in an inactive state whilst allowing correct
localisation. Thus, permitting the rapid switching of activity characteristic of regulation by
phosphorylation.
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